3D Structure of a Plant Peptide That Inhibits HIV Reveals How It Works

The anti-HIV cyclic peptide circulin A has a compact knotted structure with an exposed hydrophobic patch and positively charged surface that likely enable its interaction with viral membranes.

Daly, N L et al.·Journal of molecular biology·1999·Preliminary Evidencein-vitro
RPEP-00519In VitroPreliminary Evidence1999RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
in-vitro
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Circulin A's 3D structure reveals a cyclic cystine knot fold with exposed hydrophobic and positively charged surface patches, providing a structural basis for its membrane-disrupting anti-HIV activity.

Key Numbers

How They Did This

Structural biology study using 2D proton NMR spectroscopy with distance geometry and simulated annealing to determine circulin A's solution structure in water.

Why This Research Matters

Knowing the 3D structure of an anti-HIV peptide enables rational drug design — researchers can identify which structural features are essential for activity and engineer improved analogs.

The Bigger Picture

HIV continues to require lifelong treatment. Plant-derived peptides with anti-HIV activity offer potential for new drug classes, and understanding their structure is the first step toward clinical development.

What This Study Doesn't Tell Us

Structure determined in water, which may differ from conformation at viral membranes. The exact mechanism of anti-HIV activity (membrane disruption vs. specific receptor binding) was not definitively established.

Questions This Raises

  • ?Which structural features of circulin A are essential for anti-HIV activity?
  • ?Can circulin A analogs with improved potency and selectivity be designed?
  • ?Does circulin A interact with HIV's membrane or specific viral proteins?

Trust & Context

Key Stat:
Cyclic cystine knot Three interlocking disulfide bonds create an exceptionally stable structure in this anti-HIV plant peptide
Evidence Grade:
Preliminary evidence from a single structural study. Well-determined NMR structure but limited functional insight into anti-HIV mechanism.
Study Age:
Published in 1999. Circulin A's cyclotide structure class has become a major focus of peptide drug design research.
Original Title:
Solution structure by NMR of circulin A: a macrocyclic knotted peptide having anti-HIV activity.
Published In:
Journal of molecular biology, 285(1), 333-45 (1999)
Database ID:
RPEP-00519

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

How can a plant peptide fight HIV?

Circulin A likely disrupts viral membranes using its hydrophobic and charged surface patches. Since HIV is an enveloped virus, disrupting its lipid membrane can prevent infection.

Why is the circular structure important?

The circular backbone with knotted disulfide bonds makes circulin A extremely resistant to degradation. This stability is rare among peptides and makes it a valuable template for drug design.

Read More on RethinkPeptides

Cite This Study

RPEP-00519·https://rethinkpeptides.com/research/RPEP-00519

APA

Daly, N L; Koltay, A; Gustafson, K R; Boyd, M R; Casas-Finet, J R; Craik, D J. (1999). Solution structure by NMR of circulin A: a macrocyclic knotted peptide having anti-HIV activity.. Journal of molecular biology, 285(1), 333-45.

MLA

Daly, N L, et al. "Solution structure by NMR of circulin A: a macrocyclic knotted peptide having anti-HIV activity.." Journal of molecular biology, 1999.

RethinkPeptides

RethinkPeptides Research Database. "Solution structure by NMR of circulin A: a macrocyclic knott..." RPEP-00519. Retrieved from https://rethinkpeptides.com/research/daly-1999-solution-structure-by-nmr

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.